Mo Zhao works as a Biopharma investor at Orbis Investments. The firm's known portfolio counts 3 companies.
Is Mo Zhao a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Late-Stage
Contacts
Affiliated funds' portfolios
Biopharma investor at Orbis Investments, whose known portfolio counts 3 companies
- Nebius
- Peplin
- RXO
Investor Profile
Stage-wise, the deals at Orbis Investments cluster around Late-Stage rounds.
The firm portfolio and the focus above give founders context on whether Mo Zhao matches their raise.
Colleagues at Orbis Investments
Frequently asked questions
Who is Mo Zhao?
Mo Zhao is a private equity investor and venture debt investor based in London, England, United Kingdom, listed as Biopharma investor at Orbis Investments. The known portfolio of that firm counts 3 companies. That portfolio belongs to the firm, not to Mo Zhao personally.
What stage does Mo Zhao invest at?
Orbis Investments appears in Late-Stage rounds across its known deals, and Mo Zhao is listed there as Biopharma investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Mo Zhao listed at?
Mo Zhao is listed as Biopharma investor at Orbis Investments. One other person in the database shares a firm with Mo Zhao.
How do I contact Mo Zhao?
An email address, a phone number and a LinkedIn page are on file for Mo Zhao. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal